Charmquark TWEE 13D and 13G filings for ImmunoPrecise Antibodies Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-24 1:58 pm Purchase |
2024-12-31 | 13G | ImmunoPrecise Antibodies Ltd. IPA |
Charmquark TWEE | 1,828,365 5.800% |
262,500 (+16.76%) |
Filing |
| 2024-01-10 1:53 pm Unchanged |
2022-12-31 | 13G | ImmunoPrecise Antibodies Ltd. IPA |
Charmquark TWEE | 1,565,865 6.280% |
0 (Unchanged) |
Filing |
| 2024-01-10 1:33 pm Purchase |
2022-04-13 | 13G | ImmunoPrecise Antibodies Ltd. IPA |
Charmquark TWEE | 1,565,865 6.400% |
1,565,865 (New Position) |
Filing |